Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat
Skelly, B.J., Petrus, D.J. and Nicholls, P.K. (2003) Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat. Journal of Small Animal Practice, 44 (6). pp. 269-272.
|PDF - Authors' Version |
*Subscription may be required
Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use of the steroid synthesis inhibitor trilostane for the treatment of hyperadrenocorticism in a domestic shorthaired cat with pituitary-dependent disease. Although trilostane was able to alleviate the severity of the clinical signs and was well tolerated, the cat subsequently died of renal failure secondary to a fungal infection of the urinary tract.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||School of Veterinary and Biomedical Sciences|
|Copyright:||British Small Animal Veterinary Association|
|Item Control Page|